We are live on ! Find out more
Peter Svennilson

Peter Svennilson Portfolio holdings

AUM $1.23B Turnover 25%
1-Year Est. Return 301.34%
This Fund
S&P 500
This Quarter Est. Return
+153.47%
1 Year Est. Return
+301.34%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$188M
AUM Growth
+$74.3M
Cap. Flow
+$9
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
1
Reduced
–
Closed
–
Avg Time Held
0.3 years
Top 10 Avg Time Held
0.3 years
Top 20 Avg Time Held
0.3 years

Top Buys

Rank Stock Value
1
CNST
Constellation Pharmaceuticals
CNST
+$9

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
CNST
1
DELISTED
Constellation Pharmaceuticals
CNST
$63.4M 33.76%
4,677,939
+1
+0% +$9
2018 Q4
1 quarter
RCUS icon
2
Arcus Biosciences
RCUS
$2.25B
$44.2M 23.56%
3,540,850
– –
2018 Q4
1 quarter
GRTS icon
3
DELISTED
Gritstone bio
GRTS
$41.3M 21.98%
3,102,934
– –
2018 Q4
1 quarter
IMDZ
4
DELISTED
Immune Design
IMDZ
$38.9M 20.7%
6,642,942
– –
2018 Q4
1 quarter

Similar funds

Peter Svennilson's Q1 2019 Portfolio in Review

As of Q1 2019, Peter Svennilson held 4 positions worth $188M, up 65% from $113M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q1 2019: portfolio turnover was 0%. Peter Svennilson opened no new positions and made no exits, leaving the 4-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Peter Svennilson added most to Constellation Pharmaceuticals in Q1 2019, an estimated $9 increase.
  • Peter Svennilson's ten largest holdings make up 100% of its $188M portfolio in Q1 2019.
  • Peter Svennilson opened 0 new positions and closed 0 in Q1 2019.
  • Peter Svennilson's portfolio value rose 65% quarter-over-quarter to $188M.

Based on Peter Svennilson's 13F filing for Q1 2019, filed 8 May 2019.